<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=192888919167017&amp;ev=PageView&amp;noscript=1">
Thursday, March 28, 2024
March 28, 2024

Linkedin Pinterest

Pacific Northwest National Laboratory inventions go public

By Annette Cary, Tri-City Herald
Published: February 6, 2018, 5:17pm

RICHLAND — More products developed from research at Pacific Northwest National Laboratory are making their way into the marketplace.

New ways of preventing cyberattacks, better blood testing and a versatile way to use solar energy developed at the Department of Energy laboratory at Richland have been licensed to companies.

PNNL’s efforts to find commercial partners interested in bringing the technology to market have been recognized by the Federal Laboratory Consortium.

The consortium recently gave PNNL three awards for excellence in technology transfer, bringing its total to 88 since the awards program was launched in 1984. It is more than any other national lab.

“Since the laboratory was created in 1965, our scientists and engineers have prided themselves on working with private industry to find additional uses for government-developed technologies that directly affect people’s lives,” said Lee Cheatham, PNNL director of technology deployment and outreach.

Technologies receiving awards include:

• A record-setting 70 percent of solar energy can be converted into chemical energy with STARS, or Solar Thermochemical Advanced Reactor System, according to PNNL.

The chemical energy can be used either for transportation or to produce electricity.

Concentrated sunlight is used to convert natural gas or other chemicals into a more energy-rich fuel.

A Richland-based spinoff company, STARS Technology, made up of three former PNNL employees and an industry mentor, has a license to commercialize the technology.

• Technology that can look for biomarkers in blood samples, such as lipids and metabolites, has promise for allowing doctors to personalize medicine based on a patient’s blood test results.

The biomarkers found can indicate disease before symptoms may be evident.

The technology is 1,000 times faster than other typical analysis methods of complex biological samples and has unprecedented sensitivity to identify trace amounts of molecules, according to PNNL.

A startup company, MOBILion System Inc., has held a license for the technology since January 2017. It is called SLIM, for Structures for Lossless Ion Manipulation.

• Three new cybersecurity technologies that can be used together are being commercialized by startup Cynash Inc., which is producing software that should be ready to market midyear.

The Department of Homeland Security’s Transition to Practice Program stepped in to help find entrepreneurs and potential investors.

PNNL initially provided an exploratory license to allow Cynash to “test drive” the technology before it acquired an exclusive commercial license.

Loading...